← FDA Drug Approvals (Drugs@FDA)
CLOTRIMAZOLE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: THINQ PHARM-CRO PVT · Approved 2024-02-29
Drug application
- FDA Application #
ANDA215641
- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CLOTRIMAZOLE
- Generic name
- CLOTRIMAZOLE
- Active ingredients
- CLOTRIMAZOLE
- Dosage form
- TROCHE/LOZENGE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- THINQ PHARM-CRO PVT
- Manufacturer
- Rising Pharma Holdings, Inc.
- First approval
- 2024-02-29
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown